{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:34:28Z","timestamp":1792017268358,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2020YFC2005600"],"award-info":[{"award-number":["2020YFC2005600"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2020YFC2005605"],"award-info":[{"award-number":["2020YFC2005605"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jamda.2025.106038","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T17:00:12Z","timestamp":1767805212000},"page":"106038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Nutritional and Pharmacological Interventions for Sarcopenia in Older Adults: A Systematic Review and Network Meta-Analysis"],"prefix":"10.1016","volume":"27","author":[{"given":"Meng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjiao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3730-779X","authenticated-orcid":false,"given":"Jirong","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiukui","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2025.106038_bib1","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1016\/S0140-6736(19)31138-9","article-title":"Sarcopenia","volume":"393","author":"Cruz-Jentoft","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jamda.2025.106038_bib2","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.3390\/nu13051441","article-title":"The prevalence of Sarcopenia in Chinese older adults: meta-analysis and meta-regression","volume":"13","author":"Chen","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.jamda.2025.106038_bib3","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/ageing\/afz046","article-title":"Writing group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the extended group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"10.1016\/j.jamda.2025.106038_bib4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/jcsm.12411","article-title":"Sarcopenia and its association with falls and fractures in older adults: a systematic review and meta-analysis","volume":"10","author":"Yeung","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jamda.2025.106038_bib5","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12877-018-0878-0","article-title":"Sarcopenia as a predictor of hospitalization among older people: a systematic review and meta-analysis","volume":"18","author":"Zhang","year":"2018","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.jamda.2025.106038_bib6","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.clnu.2018.09.026","article-title":"Financial impact of sarcopenia or low muscle mass - a short review","volume":"38","author":"Norman","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jamda.2025.106038_bib7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/1747-0080.12287","article-title":"Sarcopenia and hospitalisation costs in older adults: a cross-sectional study","volume":"74","author":"Antunes","year":"2017","journal-title":"Nutr Diet"},{"key":"10.1016\/j.jamda.2025.106038_bib8","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.2147\/CIA.S150826","article-title":"The increase in health care costs associated with muscle weakness in older people without long-term illnesses in the Czech republic: results from the Survey of Health, Ageing and Retirement in Europe (SHARE)","volume":"12","author":"Steffl","year":"2017","journal-title":"Clin Interv Aging"},{"issue":"7","key":"10.1016\/j.jamda.2025.106038_bib9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2174\/1389203717666161227144349","article-title":"Nutrition and exercise in Sarcopenia","volume":"19","author":"nton","year":"2018","journal-title":"Curr Protein Pept Sci"},{"key":"10.1016\/j.jamda.2025.106038_bib10","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1007\/s12603-018-1139-9","article-title":"International Clinical Practice Guidelines for Sarcopenia (ICFSR): screening, diagnosis and management","volume":"22","author":"Dent","year":"2018","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.jamda.2025.106038_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1959486","article-title":"Effects of physical exercise programs on Sarcopenia management, dynapenia, and physical performance in the elderly: a systematic review of randomized clinical trials","volume":"2019","author":"De Mello","year":"2019","journal-title":"J Aging Res"},{"key":"10.1016\/j.jamda.2025.106038_bib12","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/jcsm.13225","article-title":"Exercise for sarcopenia in older people: a systematic review and network meta-analysis","volume":"14","author":"Shen","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jamda.2025.106038_bib13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.maturitas.2020.12.009","article-title":"Exercise, nutrition, and combined exercise and nutrition in older adults with Sarcopenia: a systematic review and network meta-analysis","volume":"145","author":"Wu","year":"2021","journal-title":"Maturitas"},{"key":"10.1016\/j.jamda.2025.106038_bib14","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jamda.2022.01.057","article-title":"Management of Sarcopenia: a network meta-analysis of randomized controlled trials","volume":"23","author":"Negm","year":"2022","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2025.106038_bib15","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000034254","article-title":"The efficacy of different interventions in the treatment of Sarcopenia in middle-aged and elderly people: a network meta-analysis","volume":"102","author":"Geng","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jamda.2025.106038_bib16","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s40266-018-0566-y","article-title":"Pharmacological interventions to improve muscle mass, muscle strength and physical performance in older people: an umbrella review of systematic reviews and meta-analyses","volume":"35","author":"De Spiegeleer","year":"2018","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jamda.2025.106038_bib17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.14283\/jfa.2019.11","article-title":"Development of pharmacotherapies for the treatment of Sarcopenia","volume":"8","author":"Rooks","year":"2019","journal-title":"J Frailty Aging"},{"key":"10.1016\/j.jamda.2025.106038_bib18","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/S2666-7568(21)00084-2","article-title":"Bimagrumab to improve recovery after hip fracture in older adults: a multicentre, double-blind, randomised, parallel-group, placebo-controlled, phase 2a\/b trial","volume":"2","author":"Hofbauer","year":"2021","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.jamda.2025.106038_bib19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s12603-013-0335-x","article-title":"A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the Selective Androgen Receptor Modulator (SARM), MK-0773 in female participants with Sarcopenia","volume":"17","author":"Papanicolaou","year":"2013","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.jamda.2025.106038_bib20","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jamda.2025.106038_bib21","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2025.106038_bib22","first-page":"378","article-title":"Comprehensive intervention for Sarcopenia among older adults: an evidence-based clinical practice guideline","volume":"24","author":"Shen","year":"2024","journal-title":"Chin J Evid-based Med"},{"key":"10.1016\/j.jamda.2025.106038_bib23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1745-6215-10-46","article-title":"Randomized trials published in some Chinese journals: how many are randomized?","volume":"2","author":"Wu","year":"2009","journal-title":"Trials"},{"key":"10.1016\/j.jamda.2025.106038_bib24","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 6.2","author":"Higgins","year":"2021"},{"key":"10.1016\/j.jamda.2025.106038_bib25","author":"Gordon"},{"key":"10.1016\/j.jamda.2025.106038_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g5630","article-title":"GRADE working group. A GRADE working group approach for rating the quality of treatment effect estimates from network meta-analysis","volume":"349","author":"Puhan","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2025.106038_bib27","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.3390\/nu13103589","article-title":"The optimal strategy of vitamin D for Sarcopenia: a network meta-analysis of randomized controlled trials","volume":"13","author":"Cheng","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.jamda.2025.106038_bib28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s40520-024-02920-6","article-title":"Seeking optimal non-pharmacological interventions for sarcopenia: a systematic review and network meta-analysis","volume":"37","author":"Fu","year":"2025","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.jamda.2025.106038_bib29","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s40266-018-0566-y","volume":"35","author":"De Spiegeleer","year":"2018","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jamda.2025.106038_bib30","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.20836","article-title":"Bimagrumab vs optimized standard of care for treatment of sarcopenia in community-dwelling older adults: a randomized clinical trial","volume":"3","author":"Rooks","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jamda.2025.106038_bib31","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s12603-013-0335-x","article-title":"A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the Selective Androgen Receptor Modulator (SARM), MK-0773 in female participants with sarcopenia","volume":"17","author":"Papanicolaou","year":"2013","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.jamda.2025.106038_bib32","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.clnu.2025.06.007","article-title":"Therapeutic advances in sarcopenia management: from traditional interventions to personalized medicine","volume":"51","author":"Liu","year":"2025","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jamda.2025.106038_bib33","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ncb1101-1009","article-title":"Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K\/Akt\/mTOR and PI(3)K\/Akt\/GSK3 pathways","volume":"3","author":"Rommel","year":"2001","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jamda.2025.106038_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-03070-z","article-title":"Effects of strength training on neuromuscular adaptations in the development of maximal strength: a systematic review and meta-analysis","volume":"15","author":"Rong","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.jamda.2025.106038_bib35","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1080\/13543784.2020.1777275","article-title":"Selective Androgen Receptor Modulators (SARMs) as pharmacological treatment for muscle wasting in ongoing clinical trials","volume":"29","author":"Fonseca","year":"2020","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jamda.2025.106038_bib36","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41572-024-00550-w","article-title":"Sarcopenia","volume":"10","author":"Sayer","year":"2024","journal-title":"Nat Rev Dis Primers"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861025005559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861025005559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T22:38:35Z","timestamp":1773959915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861025005559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1525861025005559"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2025.106038","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nutritional and Pharmacological Interventions for Sarcopenia in Older Adults: A Systematic Review and Network Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2025.106038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Post-Acute and Long-Term Care Medical Association.","name":"copyright","label":"Copyright"}],"article-number":"106038"}}